Allogene retains control of cancer therapy after arbitration ruling
Go back to Allogene retains control of cancer therapy after arbitration ruling| (NASDAQ: ALLO) | Delayed: 1.96 -0.03 (1.51%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.99 | 52 Week High | $ | |||
| Open | $1.97 | 52 Week Low | $ | |||
| Day High | $2.04 | P/E | N/A | |||
| Day Low | $1.91 | EPS | $ | |||
| Volume | 4,038,251 | |||||
| (NASDAQ: CLLS) | Delayed: 3.34 +0.04 (1.21%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.30 | 52 Week High | $37.55 | |||
| Open | $3.32 | 52 Week Low | $16.35 | |||
| Day High | $3.34 | P/E | N/A | |||
| Day Low | $3.22 | EPS | $0.00 | |||
| Volume | 5,970 | |||||
